Posttraumatic Stress Disorder
Conditions
Keywords
PTSD, Cognitive Function
Brief summary
Approximately half a million Veterans receiving services at the VA have Posttraumatic Stress Disorder (PTSD). PTSD is strongly associated with cognitive functioning deficits in areas of concentration, attention, memory, learning, verbal abilities, processing speed, and multitasking. Compensatory Cognitive Training (CCT) is an evidence-based intervention for cognitive problems that is effective in other Veteran populations such as those with a history of traumatic brain injury (TBI), but CCT has not yet been tested in Veterans with PTSD who don't have a history of TBI. The investigators will conduct a pilot randomized controlled trial (RCT) of CCT in Veterans who have been treated for PTSD but continue to have cognitive functioning deficits. The investigators will examine feasibility, acceptability, participant characteristics, and effect size estimates in preparation for a fully-powered RCT of CCT for PTSD-related cognitive functioning deficits.
Detailed description
Project Background: PTSD is associated with deficits in cognitive functioning including memory, learning, processing speed, concentration, attention, and executive functioning. Though many Veterans benefit from evidence-based psychotherapy (EBP) for PTSD, many Veterans have cognitive functioning deficits even after completing EBP for PTSD. There are no evidence-based treatments for these Veterans. Compensatory Cognitive Training (CCT) is improves cognitive functioning in Veterans with brain injury history, but is not yet tested in Veterans with PTSD. Project Aims: This study will evaluate feasibility, acceptability, and participant characteristics, and estimate effect sizes, in a pilot test of CCT for Veterans with PTSD-related cognitive problems. Data from this study will form the basis for a future, fully powered trial testing the effectiveness of CCT for cognitive problems in Veterans with PTSD. Project Methods: The investigators will recruit Veterans from local VA mental health clinics, using the VA's Corporate Data Warehouse (CDW) to identify potentially eligible Veterans if needed. The investigators will compare CCT vs. treatment as usual for 36 Veterans with PTSD-related cognitive functioning deficits. The investigators will calculate rates of recruitment, retention, and intervention participation. Statistical significance will be examined, though the investigators' focus will be on effect size estimates, score ranges, and variability to plan for a follow-up, fully powered RCT. Anticipated Impact: PTSD-related cognitive functioning deficits are a significant problem for many Veterans. CCT is an effective cognitive rehabilitation intervention for Veterans with a history of brain injury, but VA clinicians need data on its effectiveness for Veterans with PTSD-related cognitive functioning deficits. These studies will provide the data necessary for a larger scale RCT proposal if results show that CCT is as promising as expected for Veterans with PTSD.
Interventions
Compensatory Cognitive Training draws from the theoretical literature on compensatory strategy training for other cognitively impaired populations (e.g., Huckans et al., 2013; Twamley et al., 2010; Storzbach et al., 2016). It is a rehabilitation model that aims to teach individuals strategies that allow them to work around cognitive deficits. Consistent with this model and the expert recommendations for civilians and Service members with TBI (Cicerone, 2011), manualized CCT treatment provides training in compensatory attention and learning/memory skills, formal problem-solving strategies applied to daily problems, and the use of external aids such as calendar systems and assistive devices to promote completion of daily tasks (Storzbach et al., 2016).
All TAU participants have an ongoing VA mental health provider and received ongoing mental health care during the course of the study (generally weekly individual or group sessions focusing on evidence-based PTSD treatment).
Sponsors
Study design
Masking description
Assessors will be masked to participant condition.
Intervention model description
This is a parallel randomized controlled pilot trial.
Eligibility
Inclusion criteria
* Eligible Veterans must meet Diagnostic and Statistical Manual 5 (DSM-5) criteria for PTSD with evidence-based PTSD treatment participation within the past 2 years. * Must have an individual mental health provider/case manager assigned for coordination of care and management of crises as well as provision of treatment as usual if Veteran is randomly assigned to this condition. * Report subjective cognitive complaints, such as problems with memory, attention/concentration, and executive function (e.g., planning, organization, problem-solving, decision-making). * Referring provider observes mild cognitive problems that interfere with daily life (e.g., forgetting appointments or medications, poor performance at work or school, difficulty remembering information, trouble focusing in treatment sessions, trouble following through on goals). * Fluent English speaker. * Able to read and write and provide informed consent.
Exclusion criteria
* No history of traumatic brain injury (tbi) of any severity or another major medical condition likely to significantly impact cognitive functioning such as stroke, multiple sclerosis (MS), Parkinson's, or a brain tumor. * Do not meet criteria for bipolar disorder or a psychotic disorder. Do not have a diagnosis of a substance dependence disorder within the past 30 days. * Do not have active suicidal intent indicating significant clinical risk (which would suggest that a treatment targeting suicidal intent is indicated). * Cognitive problems are not severe (i.e., no dementia). Cognitive problems do NOT interfere with a Veteran's overall ability to live independently or care for him/herself. * Not currently participating in any type of brain stimulation treatment. * No significant auditory/visual impairments.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| California Verbal Learning Test (CVLT-II; Delis et al., 2000) | change from baseline to 3 and 6 months | Comprehensive measurement of verbal learning and memory and includes a forced choice validity. The total raw score is the sum of correct responses on the five presentations; scores range from 0-80. Higher scores represent better outcomes. |
| Prospective-Retrospective Memory Questionnaire (PRMQ; Crawford et al., 2006) | change from baseline to 3 and 6 months | Self-report severity measure of prospective (remembering to do something in the future) and retrospective (remembering something from the past) memory problems relevant to every day life. Higher scores represent worse outcomes. Total score ranges from 0-64. |
| Multiple Sclerosis Neuropsychological Screening Questionnaire - Patient Version (MSNQ; Benedict et al., 2003) | change from baseline to 3 and 6 months | Self-report severity measure of attention and organizational problems. Scores on the MSNQ range from 0 to 58, with higher scores indicating greater cognitive impairment. |
| Wechsler Adult Intelligence Scale (WAIS-IV) Coding Subtest (Wechsler, 2008) | change from baseline to 3 and 6 months | A measure of processing speed. Higher scores represent better outcomes. Scores range from 0-155. |
| Controlled Oral Word Association Test (Benton, Hamsher, & Sivan, 1983) | change from baseline to 3 and 6 months | The Controlled Oral Word Association (COWA) Test measures word generation, verbal fluency, and executive functioning. Participants are asked to name as many words as they can starting with a specific letter (i.e., F, A, S) within one minute, and as many words as possible in a specified category (i.e., animals) within one minute. Total score is the sum of responses (three letter trials, one category trial). Higher scores represent better outcomes. Total score ranges are affected by age and education. |
| Halstead Reitan Trailmaking Test (Trails A & B; Reitan & Wolfson, 1985) | change from baseline to 3 and 6 months | Measures visual tracking, processing speed, and executive functioning. Scores represent the amount of time to complete the task (in seconds), range from 10-366, and higher numbers represent worse outcomes. |
| World Health Organization Disability Assessment Scale (WHODAS 2.0) | change from baseline to 3 and 6 months | Self-report measure of quality of life and global functioning. Higher scores represent worse outcomes. Total score ranges from 0-144. |
| Quality of Life in Neurological Disorders (Neuro-QOL): Cognitive, Ability to Participate in Social Roles and Activities, and Sleep Scales | change from baseline to 3 and 6 months | Self-report measure of quality of life, cognitive functioning, sleep functioning, and social functioning. Higher scores represent lower functioning. Total scores range from 52 to 260. |
| Memory Compensation Questionnaire (MCQ; de Frias & Dixon, 2005) | change from baseline to 3 and 6 months | A 44-item self-report questionnaire that rates the extent of use of various strategies to improve memory performance relevant to daily living. Higher scores represent better outcomes. Total score ranges from 0-176. |
| Portland Cognitive Strategies Scale 2.0 (PCSS) | change from baseline to 3 and 6 months | Measures compensatory cognitive strategy use through two scales; how often skills are used and how useful. Higher scores represent more skill use and more perceived usefulness. Total score ranges from 0-60 per scale. |
| Wechsler Adult Intelligence Scale (WAIS-IV) Digit Span Subtest (Wechsler, 2008) | change from baseline to 3 and 6 months | Measures attention, working memory, processing speed, and reliable digit span validity. Higher scores represent better outcomes. Scores on each subtest (forward, backward, and sequential) range from 0-16 and are reported as WAIS Scaled Scores. Total score (range 0-48) is the sum of each subtest. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| PTSD Checklist (PCL-5; Weathers et al., 2013) | change from baseline to 3 and 6 months | PTSD symptoms and severity. Higher scores indicates more severe symptomology. Total score ranges from 0-80. |
| Patient Health Questionnaire (PHQ-9; Spitzer, Kroenke, & Williams, 1999) | change from baseline to 3 and 6 months | A brief, nine-item depression assessment questionnaire used to screen for depression and monitor its severity. Higher scores represent worse outcomes. Total score ranges from 0-27. |
Countries
United States
Contacts
VA Portland Health Care System, Portland, OR
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Compensatory Cognitive Training (CCT) Compensatory Cognitive Training draws from the theoretical literature on compensatory strategy training for other cognitively impaired populations (e.g., Huckans et al., 2013; Twamley et al., 2010; Storzbach et al., 2016). It is a rehabilitation model that aims to teach individuals strategies that allow them to work around cognitive deficits. Consistent with this model and the expert recommendations for civilians and Service members with TBI (Cicerone, 2011), manualized CCT treatment provides training in compensatory attention and learning/memory skills, formal problem-solving strategies applied to daily problems, and the use of external aids such as calendar systems and assistive devices to promote completion of daily tasks (Storzbach et al., 2016). | 13 |
| Treatment as Usual (TAU) All TAU participants have an ongoing VA mental health provider and received ongoing mental health care during the course of the study (generally weekly individual or group sessions focusing on evidence-based PTSD treatment). | 8 |
| Total | 21 |
Baseline characteristics
| Characteristic | Compensatory Cognitive Training (CCT) | Treatment as Usual (TAU) | Total |
|---|---|---|---|
| Age, Continuous | 45 years STANDARD_DEVIATION 12.89 | 45.63 years STANDARD_DEVIATION 14.3 | 45.3 years STANDARD_DEVIATION 13.1 |
| Education (years) | 14.31 years STANDARD_DEVIATION 1.93 | 15.75 years STANDARD_DEVIATION 2.44 | 14.86 years STANDARD_DEVIATION 2.2 |
| Mental Health Diagnosis Agoraphobia | 9 Participants | 3 Participants | 12 Participants |
| Mental Health Diagnosis Alcohol Use Disorder | 2 Participants | 0 Participants | 2 Participants |
| Mental Health Diagnosis Generalized Anxiety Disorder | 5 Participants | 1 Participants | 6 Participants |
| Mental Health Diagnosis Major Depressive Disorder | 7 Participants | 4 Participants | 11 Participants |
| Mental Health Diagnosis Panic Disorder | 5 Participants | 1 Participants | 6 Participants |
| Mental Health Diagnosis PTSD | 13 Participants | 6 Participants | 19 Participants |
| Mental Health Diagnosis Social Anxiety | 5 Participants | 2 Participants | 7 Participants |
| Race/Ethnicity, Customized Native American | 0 Participants | 1 Participants | 1 Participants |
| Race/Ethnicity, Customized Non-Hispanic Black | 0 Participants | 2 Participants | 2 Participants |
| Race/Ethnicity, Customized Non-Hispanic White | 13 Participants | 4 Participants | 17 Participants |
| Race/Ethnicity, Customized Other | 0 Participants | 1 Participants | 1 Participants |
| Region of Enrollment United States | 13 Participants | 8 Participants | 21 Participants |
| Sex: Female, Male Female | 8 Participants | 2 Participants | 10 Participants |
| Sex: Female, Male Male | 5 Participants | 6 Participants | 11 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 13 | 0 / 8 |
| other Total, other adverse events | 0 / 13 | 0 / 13 |
| serious Total, serious adverse events | 0 / 13 | 0 / 8 |
Outcome results
California Verbal Learning Test (CVLT-II; Delis et al., 2000)
Comprehensive measurement of verbal learning and memory and includes a forced choice validity. The total raw score is the sum of correct responses on the five presentations; scores range from 0-80. Higher scores represent better outcomes.
Time frame: change from baseline to 3 and 6 months
Population: Due to drop-out and COVID precautions, there were less participants who completed measures at 3- and 6-Month follow-ups
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Compensatory Cognitive Training (CCT) | California Verbal Learning Test (CVLT-II; Delis et al., 2000) | Baseline | 52.77 score on a measure | Standard Deviation 11.047 |
| Compensatory Cognitive Training (CCT) | California Verbal Learning Test (CVLT-II; Delis et al., 2000) | 3-Month | 62.8 score on a measure | Standard Deviation 8.066 |
| Compensatory Cognitive Training (CCT) | California Verbal Learning Test (CVLT-II; Delis et al., 2000) | 6-Month | 52.333 score on a measure | Standard Deviation 9.713 |
| Treatment as Usual (TAU) | California Verbal Learning Test (CVLT-II; Delis et al., 2000) | Baseline | 52.88 score on a measure | Standard Deviation 10.602 |
| Treatment as Usual (TAU) | California Verbal Learning Test (CVLT-II; Delis et al., 2000) | 3-Month | 58.33 score on a measure | Standard Deviation 16.207 |
| Treatment as Usual (TAU) | California Verbal Learning Test (CVLT-II; Delis et al., 2000) | 6-Month | 63.857 score on a measure | Standard Deviation 14.622 |
Controlled Oral Word Association Test (Benton, Hamsher, & Sivan, 1983)
The Controlled Oral Word Association (COWA) Test measures word generation, verbal fluency, and executive functioning. Participants are asked to name as many words as they can starting with a specific letter (i.e., F, A, S) within one minute, and as many words as possible in a specified category (i.e., animals) within one minute. Total score is the sum of responses (three letter trials, one category trial). Higher scores represent better outcomes. Total score ranges are affected by age and education.
Time frame: change from baseline to 3 and 6 months
Population: Due to drop-out and COVID precautions, there were less participants who completed measures at 3- and 6-Month follow-ups
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Compensatory Cognitive Training (CCT) | Controlled Oral Word Association Test (Benton, Hamsher, & Sivan, 1983) | Categories - Baseline | 24.38 Number of words | Standard Deviation 6.423 |
| Compensatory Cognitive Training (CCT) | Controlled Oral Word Association Test (Benton, Hamsher, & Sivan, 1983) | Letters - Baseline | 42.69 Number of words | Standard Deviation 11.828 |
| Compensatory Cognitive Training (CCT) | Controlled Oral Word Association Test (Benton, Hamsher, & Sivan, 1983) | Letters - 6-Months | 47.000 Number of words | Standard Deviation 12.288 |
| Compensatory Cognitive Training (CCT) | Controlled Oral Word Association Test (Benton, Hamsher, & Sivan, 1983) | Letters - 3-Months | 40.00 Number of words | Standard Deviation 14.169 |
| Compensatory Cognitive Training (CCT) | Controlled Oral Word Association Test (Benton, Hamsher, & Sivan, 1983) | Categories - 6-Months | 23.667 Number of words | Standard Deviation 3.786 |
| Compensatory Cognitive Training (CCT) | Controlled Oral Word Association Test (Benton, Hamsher, & Sivan, 1983) | Categories - 3-Months | 22.667 Number of words | Standard Deviation 6.614 |
| Treatment as Usual (TAU) | Controlled Oral Word Association Test (Benton, Hamsher, & Sivan, 1983) | Categories - 6-Months | 23.429 Number of words | Standard Deviation 3.101 |
| Treatment as Usual (TAU) | Controlled Oral Word Association Test (Benton, Hamsher, & Sivan, 1983) | Letters - Baseline | 44.75 Number of words | Standard Deviation 11.829 |
| Treatment as Usual (TAU) | Controlled Oral Word Association Test (Benton, Hamsher, & Sivan, 1983) | Categories - Baseline | 27.0 Number of words | Standard Deviation 5.21 |
| Treatment as Usual (TAU) | Controlled Oral Word Association Test (Benton, Hamsher, & Sivan, 1983) | Letters - 3-Months | 46.0 Number of words | Standard Deviation 10.017 |
| Treatment as Usual (TAU) | Controlled Oral Word Association Test (Benton, Hamsher, & Sivan, 1983) | Categories - 3-Months | 21.143 Number of words | Standard Deviation 6.669 |
| Treatment as Usual (TAU) | Controlled Oral Word Association Test (Benton, Hamsher, & Sivan, 1983) | Letters - 6-Months | 48.571 Number of words | Standard Deviation 11.559 |
Halstead Reitan Trailmaking Test (Trails A & B; Reitan & Wolfson, 1985)
Measures visual tracking, processing speed, and executive functioning. Scores represent the amount of time to complete the task (in seconds), range from 10-366, and higher numbers represent worse outcomes.
Time frame: change from baseline to 3 and 6 months
Population: Due to drop-out and COVID precautions, there were less participants who completed measures at 3- and 6-Month follow-ups
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Compensatory Cognitive Training (CCT) | Halstead Reitan Trailmaking Test (Trails A & B; Reitan & Wolfson, 1985) | Trails A - Baseline | 26.62 Seconds | Standard Deviation 4.84 |
| Compensatory Cognitive Training (CCT) | Halstead Reitan Trailmaking Test (Trails A & B; Reitan & Wolfson, 1985) | Trails B - Baseline | 58.85 Seconds | Standard Deviation 12.089 |
| Compensatory Cognitive Training (CCT) | Halstead Reitan Trailmaking Test (Trails A & B; Reitan & Wolfson, 1985) | Trails A - 3-Month | 22.125 Seconds | Standard Deviation 6.999 |
| Compensatory Cognitive Training (CCT) | Halstead Reitan Trailmaking Test (Trails A & B; Reitan & Wolfson, 1985) | Trails B - 3-Month | 46.5 Seconds | Standard Deviation 9.15 |
| Compensatory Cognitive Training (CCT) | Halstead Reitan Trailmaking Test (Trails A & B; Reitan & Wolfson, 1985) | Trails A - 6-Month | 12.0 Seconds | Standard Deviation 0 |
| Compensatory Cognitive Training (CCT) | Halstead Reitan Trailmaking Test (Trails A & B; Reitan & Wolfson, 1985) | Trails B - 6-Month | 38.0 Seconds | Standard Deviation 0 |
| Treatment as Usual (TAU) | Halstead Reitan Trailmaking Test (Trails A & B; Reitan & Wolfson, 1985) | Trails A - 6-Month | 20.571 Seconds | Standard Deviation 6.554 |
| Treatment as Usual (TAU) | Halstead Reitan Trailmaking Test (Trails A & B; Reitan & Wolfson, 1985) | Trails A - Baseline | 22.50 Seconds | Standard Deviation 9.071 |
| Treatment as Usual (TAU) | Halstead Reitan Trailmaking Test (Trails A & B; Reitan & Wolfson, 1985) | Trails B - 3-Month | 45.0 Seconds | Standard Deviation 15.663 |
| Treatment as Usual (TAU) | Halstead Reitan Trailmaking Test (Trails A & B; Reitan & Wolfson, 1985) | Trails B - Baseline | 50.63 Seconds | Standard Deviation 10.542 |
| Treatment as Usual (TAU) | Halstead Reitan Trailmaking Test (Trails A & B; Reitan & Wolfson, 1985) | Trails B - 6-Month | 45.286 Seconds | Standard Deviation 9.411 |
| Treatment as Usual (TAU) | Halstead Reitan Trailmaking Test (Trails A & B; Reitan & Wolfson, 1985) | Trails A - 3-Month | 20.0 Seconds | Standard Deviation 6.481 |
Memory Compensation Questionnaire (MCQ; de Frias & Dixon, 2005)
A 44-item self-report questionnaire that rates the extent of use of various strategies to improve memory performance relevant to daily living. Higher scores represent better outcomes. Total score ranges from 0-176.
Time frame: change from baseline to 3 and 6 months
Population: Due to drop-out and COVID precautions, there were less participants who completed measures at 3- and 6-Month follow-ups
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Compensatory Cognitive Training (CCT) | Memory Compensation Questionnaire (MCQ; de Frias & Dixon, 2005) | Baseline | 105.38 score on a scale | Standard Deviation 26.943 |
| Compensatory Cognitive Training (CCT) | Memory Compensation Questionnaire (MCQ; de Frias & Dixon, 2005) | 3-Month | 91.125 score on a scale | Standard Deviation 22.106 |
| Compensatory Cognitive Training (CCT) | Memory Compensation Questionnaire (MCQ; de Frias & Dixon, 2005) | 6-Month | 104.4 score on a scale | Standard Deviation 48.19 |
| Treatment as Usual (TAU) | Memory Compensation Questionnaire (MCQ; de Frias & Dixon, 2005) | Baseline | 101.88 score on a scale | Standard Deviation 30.954 |
| Treatment as Usual (TAU) | Memory Compensation Questionnaire (MCQ; de Frias & Dixon, 2005) | 3-Month | 86.25 score on a scale | Standard Deviation 47.528 |
| Treatment as Usual (TAU) | Memory Compensation Questionnaire (MCQ; de Frias & Dixon, 2005) | 6-Month | 91.143 score on a scale | Standard Deviation 38.507 |
Multiple Sclerosis Neuropsychological Screening Questionnaire - Patient Version (MSNQ; Benedict et al., 2003)
Self-report severity measure of attention and organizational problems. Scores on the MSNQ range from 0 to 58, with higher scores indicating greater cognitive impairment.
Time frame: change from baseline to 3 and 6 months
Population: Due to drop-out and COVID precautions, there were less participants who completed measures at 3- and 6-Month follow-ups
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Compensatory Cognitive Training (CCT) | Multiple Sclerosis Neuropsychological Screening Questionnaire - Patient Version (MSNQ; Benedict et al., 2003) | Baseline | 33.15 score on a scale | Standard Deviation 8.143 |
| Compensatory Cognitive Training (CCT) | Multiple Sclerosis Neuropsychological Screening Questionnaire - Patient Version (MSNQ; Benedict et al., 2003) | 3-Month | 29.375 score on a scale | Standard Deviation 7.52 |
| Compensatory Cognitive Training (CCT) | Multiple Sclerosis Neuropsychological Screening Questionnaire - Patient Version (MSNQ; Benedict et al., 2003) | 6-Month | 22.6 score on a scale | Standard Deviation 14.117 |
| Treatment as Usual (TAU) | Multiple Sclerosis Neuropsychological Screening Questionnaire - Patient Version (MSNQ; Benedict et al., 2003) | Baseline | 22.75 score on a scale | Standard Deviation 12.903 |
| Treatment as Usual (TAU) | Multiple Sclerosis Neuropsychological Screening Questionnaire - Patient Version (MSNQ; Benedict et al., 2003) | 3-Month | 26.5 score on a scale | Standard Deviation 11.387 |
| Treatment as Usual (TAU) | Multiple Sclerosis Neuropsychological Screening Questionnaire - Patient Version (MSNQ; Benedict et al., 2003) | 6-Month | 29.833 score on a scale | Standard Deviation 14.442 |
Portland Cognitive Strategies Scale 2.0 (PCSS)
Measures compensatory cognitive strategy use through two scales; how often skills are used and how useful. Higher scores represent more skill use and more perceived usefulness. Total score ranges from 0-60 per scale.
Time frame: change from baseline to 3 and 6 months
Population: Due to drop-out and COVID precautions, there were less participants who completed measures at 3- and 6-Month follow-ups
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Compensatory Cognitive Training (CCT) | Portland Cognitive Strategies Scale 2.0 (PCSS) | Often - Baseline | 36.46 score on a scale | Standard Deviation 14.033 |
| Compensatory Cognitive Training (CCT) | Portland Cognitive Strategies Scale 2.0 (PCSS) | Useful - Baseline | 29.42 score on a scale | Standard Deviation 5.915 |
| Compensatory Cognitive Training (CCT) | Portland Cognitive Strategies Scale 2.0 (PCSS) | Often - 3-Months | 31.182 score on a scale | Standard Deviation 21.042 |
| Compensatory Cognitive Training (CCT) | Portland Cognitive Strategies Scale 2.0 (PCSS) | Useful - 3-Months | 30.875 score on a scale | Standard Deviation 2.8 |
| Compensatory Cognitive Training (CCT) | Portland Cognitive Strategies Scale 2.0 (PCSS) | Often - 6-Months | 45.0 score on a scale | Standard Deviation 9.823 |
| Compensatory Cognitive Training (CCT) | Portland Cognitive Strategies Scale 2.0 (PCSS) | Useful - 6-Months | 32.8 score on a scale | Standard Deviation 4.087 |
| Treatment as Usual (TAU) | Portland Cognitive Strategies Scale 2.0 (PCSS) | Often - 6-Months | 44.833 score on a scale | Standard Deviation 8.565 |
| Treatment as Usual (TAU) | Portland Cognitive Strategies Scale 2.0 (PCSS) | Often - Baseline | 45.88 score on a scale | Standard Deviation 8.202 |
| Treatment as Usual (TAU) | Portland Cognitive Strategies Scale 2.0 (PCSS) | Useful - 3-Months | 29.00 score on a scale | Standard Deviation 2.708 |
| Treatment as Usual (TAU) | Portland Cognitive Strategies Scale 2.0 (PCSS) | Useful - Baseline | 33.63 score on a scale | Standard Deviation 4.984 |
| Treatment as Usual (TAU) | Portland Cognitive Strategies Scale 2.0 (PCSS) | Useful - 6-Months | 30.833 score on a scale | Standard Deviation 4.446 |
| Treatment as Usual (TAU) | Portland Cognitive Strategies Scale 2.0 (PCSS) | Often - 3-Months | 31.167 score on a scale | Standard Deviation 21.17 |
Prospective-Retrospective Memory Questionnaire (PRMQ; Crawford et al., 2006)
Self-report severity measure of prospective (remembering to do something in the future) and retrospective (remembering something from the past) memory problems relevant to every day life. Higher scores represent worse outcomes. Total score ranges from 0-64.
Time frame: change from baseline to 3 and 6 months
Population: Due to drop-out and COVID precautions, there were less participants who completed measures at 3- and 6-Month follow-ups
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Compensatory Cognitive Training (CCT) | Prospective-Retrospective Memory Questionnaire (PRMQ; Crawford et al., 2006) | Baseline | 50.38 score on a scale | Standard Deviation 10.145 |
| Compensatory Cognitive Training (CCT) | Prospective-Retrospective Memory Questionnaire (PRMQ; Crawford et al., 2006) | 3-Month | 47.875 score on a scale | Standard Deviation 9.96 |
| Compensatory Cognitive Training (CCT) | Prospective-Retrospective Memory Questionnaire (PRMQ; Crawford et al., 2006) | 6-Month | 39.8 score on a scale | Standard Deviation 13.846 |
| Treatment as Usual (TAU) | Prospective-Retrospective Memory Questionnaire (PRMQ; Crawford et al., 2006) | Baseline | 38.5 score on a scale | Standard Deviation 15.875 |
| Treatment as Usual (TAU) | Prospective-Retrospective Memory Questionnaire (PRMQ; Crawford et al., 2006) | 3-Month | 42.5 score on a scale | Standard Deviation 16.01 |
| Treatment as Usual (TAU) | Prospective-Retrospective Memory Questionnaire (PRMQ; Crawford et al., 2006) | 6-Month | 45.857 score on a scale | Standard Deviation 16.406 |
Quality of Life in Neurological Disorders (Neuro-QOL): Cognitive, Ability to Participate in Social Roles and Activities, and Sleep Scales
Self-report measure of quality of life, cognitive functioning, sleep functioning, and social functioning. Higher scores represent lower functioning. Total scores range from 52 to 260.
Time frame: change from baseline to 3 and 6 months
Population: Due to drop-out and COVID precautions, there were less participants who completed measures at 3- and 6-Month follow-ups
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Compensatory Cognitive Training (CCT) | Quality of Life in Neurological Disorders (Neuro-QOL): Cognitive, Ability to Participate in Social Roles and Activities, and Sleep Scales | Baseline | 76.00 scores on a scale | Standard Deviation 16.703 |
| Compensatory Cognitive Training (CCT) | Quality of Life in Neurological Disorders (Neuro-QOL): Cognitive, Ability to Participate in Social Roles and Activities, and Sleep Scales | 3-Months | 88.375 scores on a scale | Standard Deviation 19.175 |
| Compensatory Cognitive Training (CCT) | Quality of Life in Neurological Disorders (Neuro-QOL): Cognitive, Ability to Participate in Social Roles and Activities, and Sleep Scales | 6-Months | 100.6 scores on a scale | Standard Deviation 30.867 |
| Treatment as Usual (TAU) | Quality of Life in Neurological Disorders (Neuro-QOL): Cognitive, Ability to Participate in Social Roles and Activities, and Sleep Scales | Baseline | 99.88 scores on a scale | Standard Deviation 31.904 |
| Treatment as Usual (TAU) | Quality of Life in Neurological Disorders (Neuro-QOL): Cognitive, Ability to Participate in Social Roles and Activities, and Sleep Scales | 3-Months | 92.00 scores on a scale | Standard Deviation 43.772 |
| Treatment as Usual (TAU) | Quality of Life in Neurological Disorders (Neuro-QOL): Cognitive, Ability to Participate in Social Roles and Activities, and Sleep Scales | 6-Months | 92.857 scores on a scale | Standard Deviation 27.267 |
Wechsler Adult Intelligence Scale (WAIS-IV) Coding Subtest (Wechsler, 2008)
A measure of processing speed. Higher scores represent better outcomes. Scores range from 0-155.
Time frame: change from baseline to 3 and 6 months
Population: Due to drop-out and COVID precautions, there were less participants who completed measures at 3- and 6-Month follow-ups
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Compensatory Cognitive Training (CCT) | Wechsler Adult Intelligence Scale (WAIS-IV) Coding Subtest (Wechsler, 2008) | Baseline | 69.38 score on a measure | Standard Deviation 12.646 |
| Compensatory Cognitive Training (CCT) | Wechsler Adult Intelligence Scale (WAIS-IV) Coding Subtest (Wechsler, 2008) | 3-Month | 77 score on a measure | Standard Deviation 17.171 |
| Compensatory Cognitive Training (CCT) | Wechsler Adult Intelligence Scale (WAIS-IV) Coding Subtest (Wechsler, 2008) | 6-Months | 88.00 score on a measure | Standard Deviation 0 |
| Treatment as Usual (TAU) | Wechsler Adult Intelligence Scale (WAIS-IV) Coding Subtest (Wechsler, 2008) | Baseline | 73.25 score on a measure | Standard Deviation 9.91 |
| Treatment as Usual (TAU) | Wechsler Adult Intelligence Scale (WAIS-IV) Coding Subtest (Wechsler, 2008) | 3-Month | 79.25 score on a measure | Standard Deviation 16.008 |
| Treatment as Usual (TAU) | Wechsler Adult Intelligence Scale (WAIS-IV) Coding Subtest (Wechsler, 2008) | 6-Months | 75.143 score on a measure | Standard Deviation 13.184 |
Wechsler Adult Intelligence Scale (WAIS-IV) Digit Span Subtest (Wechsler, 2008)
Measures attention, working memory, processing speed, and reliable digit span validity. Higher scores represent better outcomes. Scores on each subtest (forward, backward, and sequential) range from 0-16 and are reported as WAIS Scaled Scores. Total score (range 0-48) is the sum of each subtest.
Time frame: change from baseline to 3 and 6 months
Population: Due to drop-out and COVID precautions, there were less participants who completed measures at 3- and 6-Month follow-ups
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Compensatory Cognitive Training (CCT) | Wechsler Adult Intelligence Scale (WAIS-IV) Digit Span Subtest (Wechsler, 2008) | Baseline | 27.62 score on a measure | Standard Deviation 3.664 |
| Compensatory Cognitive Training (CCT) | Wechsler Adult Intelligence Scale (WAIS-IV) Digit Span Subtest (Wechsler, 2008) | 3-Months | 29.4 score on a measure | Standard Deviation 4.858 |
| Compensatory Cognitive Training (CCT) | Wechsler Adult Intelligence Scale (WAIS-IV) Digit Span Subtest (Wechsler, 2008) | 6-Months | 32.0 score on a measure | Standard Deviation 6.557 |
| Treatment as Usual (TAU) | Wechsler Adult Intelligence Scale (WAIS-IV) Digit Span Subtest (Wechsler, 2008) | Baseline | 28.88 score on a measure | Standard Deviation 6.728 |
| Treatment as Usual (TAU) | Wechsler Adult Intelligence Scale (WAIS-IV) Digit Span Subtest (Wechsler, 2008) | 3-Months | 32.33 score on a measure | Standard Deviation 1.21 |
| Treatment as Usual (TAU) | Wechsler Adult Intelligence Scale (WAIS-IV) Digit Span Subtest (Wechsler, 2008) | 6-Months | 31.571 score on a measure | Standard Deviation 4.577 |
World Health Organization Disability Assessment Scale (WHODAS 2.0)
Self-report measure of quality of life and global functioning. Higher scores represent worse outcomes. Total score ranges from 0-144.
Time frame: change from baseline to 3 and 6 months
Population: Due to drop-out and COVID precautions, there were less participants who completed measures at 3- and 6-Month follow-ups
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Compensatory Cognitive Training (CCT) | World Health Organization Disability Assessment Scale (WHODAS 2.0) | Baseline | 63.727 score on a scale | Standard Deviation 22.136 |
| Compensatory Cognitive Training (CCT) | World Health Organization Disability Assessment Scale (WHODAS 2.0) | 3-Month | 51.286 score on a scale | Standard Deviation 27.066 |
| Compensatory Cognitive Training (CCT) | World Health Organization Disability Assessment Scale (WHODAS 2.0) | 6-Month | 65.4 score on a scale | Standard Deviation 43.964 |
| Treatment as Usual (TAU) | World Health Organization Disability Assessment Scale (WHODAS 2.0) | Baseline | 43.125 score on a scale | Standard Deviation 26.167 |
| Treatment as Usual (TAU) | World Health Organization Disability Assessment Scale (WHODAS 2.0) | 3-Month | 42.5 score on a scale | Standard Deviation 40.435 |
| Treatment as Usual (TAU) | World Health Organization Disability Assessment Scale (WHODAS 2.0) | 6-Month | 52.6 score on a scale | Standard Deviation 15.534 |
Patient Health Questionnaire (PHQ-9; Spitzer, Kroenke, & Williams, 1999)
A brief, nine-item depression assessment questionnaire used to screen for depression and monitor its severity. Higher scores represent worse outcomes. Total score ranges from 0-27.
Time frame: change from baseline to 3 and 6 months
Population: Due to drop-out and COVID precautions, there were less participants who completed measures at 3- and 6-Month follow-ups
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Compensatory Cognitive Training (CCT) | Patient Health Questionnaire (PHQ-9; Spitzer, Kroenke, & Williams, 1999) | Baseline | 22.23 Score on a scale | Standard Deviation 8.228 |
| Compensatory Cognitive Training (CCT) | Patient Health Questionnaire (PHQ-9; Spitzer, Kroenke, & Williams, 1999) | 3-Months | 19.5 Score on a scale | Standard Deviation 5.155 |
| Compensatory Cognitive Training (CCT) | Patient Health Questionnaire (PHQ-9; Spitzer, Kroenke, & Williams, 1999) | 6-Months | 19.4 Score on a scale | Standard Deviation 7.127 |
| Treatment as Usual (TAU) | Patient Health Questionnaire (PHQ-9; Spitzer, Kroenke, & Williams, 1999) | Baseline | 22.25 Score on a scale | Standard Deviation 9.573 |
| Treatment as Usual (TAU) | Patient Health Questionnaire (PHQ-9; Spitzer, Kroenke, & Williams, 1999) | 3-Months | 19.0 Score on a scale | Standard Deviation 10.424 |
| Treatment as Usual (TAU) | Patient Health Questionnaire (PHQ-9; Spitzer, Kroenke, & Williams, 1999) | 6-Months | 21.571 Score on a scale | Standard Deviation 7.743 |
PTSD Checklist (PCL-5; Weathers et al., 2013)
PTSD symptoms and severity. Higher scores indicates more severe symptomology. Total score ranges from 0-80.
Time frame: change from baseline to 3 and 6 months
Population: Due to drop-out and COVID precautions, there were less participants who completed measures at 3- and 6-Month follow-ups
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Compensatory Cognitive Training (CCT) | PTSD Checklist (PCL-5; Weathers et al., 2013) | Baseline | 41.31 score on a scale | Standard Deviation 18.287 |
| Compensatory Cognitive Training (CCT) | PTSD Checklist (PCL-5; Weathers et al., 2013) | 3-Months | 36.375 score on a scale | Standard Deviation 16.792 |
| Compensatory Cognitive Training (CCT) | PTSD Checklist (PCL-5; Weathers et al., 2013) | 6-Months | 29.0 score on a scale | Standard Deviation 23.548 |
| Treatment as Usual (TAU) | PTSD Checklist (PCL-5; Weathers et al., 2013) | Baseline | 34.75 score on a scale | Standard Deviation 24.259 |
| Treatment as Usual (TAU) | PTSD Checklist (PCL-5; Weathers et al., 2013) | 3-Months | 20.0 score on a scale | Standard Deviation 27.785 |
| Treatment as Usual (TAU) | PTSD Checklist (PCL-5; Weathers et al., 2013) | 6-Months | 34.571 score on a scale | Standard Deviation 19.89 |